BY Kristie L. Kahl
Breakthroughs in immunotherapy continue to advance in the treatment landscape for cancer, but patients do not always understand what these therapies are and how they work.
This year, the Cancer Research Institute (CRI) is hosting five Immunotherapy Patient Summits for patients, caregivers and advocates to meet, get valuable information from health care experts and learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers.
For this week’s episode of “CURE
® Talks Cancer,” we spoke with a patient who underwent chimeric antigen receptor (CAR)-T cell therapy in a clinical trial, as well as CRI’s CEO, who offered more information about what these summits consist of and why they’re so helpful.
To learn more, visit: